PMC:7402624 / 31737-31972 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T280","span":{"begin":18,"end":22},"obj":"Body_part"},{"id":"T281","span":{"begin":147,"end":151},"obj":"Body_part"},{"id":"T282","span":{"begin":197,"end":200},"obj":"Body_part"},{"id":"T283","span":{"begin":215,"end":220},"obj":"Body_part"}],"attributes":[{"id":"A280","pred":"fma_id","subj":"T280","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A281","pred":"fma_id","subj":"T281","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A282","pred":"fma_id","subj":"T282","obj":"http://purl.org/sig/ont/fma/fma62876"},{"id":"A283","pred":"fma_id","subj":"T283","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"inct picture of B cell populations in COVID-19 compared to controls, whereas RD and HD were similar (Fig. 4J and fig. S5J). The COVID-19 patient B cell phenotype was dominated by loss of CXCR5 and IgD compared to B cells from HD and RD"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1189","span":{"begin":187,"end":192},"obj":"Gene"},{"id":"1207","span":{"begin":137,"end":144},"obj":"Species"},{"id":"1227","span":{"begin":38,"end":46},"obj":"Disease"},{"id":"1228","span":{"begin":84,"end":86},"obj":"Disease"},{"id":"1229","span":{"begin":128,"end":136},"obj":"Disease"},{"id":"1230","span":{"begin":226,"end":228},"obj":"Disease"}],"attributes":[{"id":"A1189","pred":"tao:has_database_id","subj":"1189","obj":"Gene:643"},{"id":"A1207","pred":"tao:has_database_id","subj":"1207","obj":"Tax:9606"},{"id":"A1227","pred":"tao:has_database_id","subj":"1227","obj":"MESH:C000657245"},{"id":"A1228","pred":"tao:has_database_id","subj":"1228","obj":"MESH:D006816"},{"id":"A1229","pred":"tao:has_database_id","subj":"1229","obj":"MESH:C000657245"},{"id":"A1230","pred":"tao:has_database_id","subj":"1230","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"inct picture of B cell populations in COVID-19 compared to controls, whereas RD and HD were similar (Fig. 4J and fig. S5J). The COVID-19 patient B cell phenotype was dominated by loss of CXCR5 and IgD compared to B cells from HD and RD"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T252","span":{"begin":38,"end":46},"obj":"Disease"},{"id":"T253","span":{"begin":77,"end":79},"obj":"Disease"},{"id":"T254","span":{"begin":84,"end":86},"obj":"Disease"},{"id":"T255","span":{"begin":128,"end":136},"obj":"Disease"},{"id":"T256","span":{"begin":226,"end":228},"obj":"Disease"},{"id":"T257","span":{"begin":233,"end":235},"obj":"Disease"}],"attributes":[{"id":"A252","pred":"mondo_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A253","pred":"mondo_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/MONDO_0009973"},{"id":"A254","pred":"mondo_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A255","pred":"mondo_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A256","pred":"mondo_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A257","pred":"mondo_id","subj":"T257","obj":"http://purl.obolibrary.org/obo/MONDO_0009973"}],"text":"inct picture of B cell populations in COVID-19 compared to controls, whereas RD and HD were similar (Fig. 4J and fig. S5J). The COVID-19 patient B cell phenotype was dominated by loss of CXCR5 and IgD compared to B cells from HD and RD"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T537","span":{"begin":16,"end":22},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T538","span":{"begin":77,"end":79},"obj":"http://purl.obolibrary.org/obo/CLO_0008770"},{"id":"T539","span":{"begin":145,"end":151},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T540","span":{"begin":213,"end":220},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T541","span":{"begin":233,"end":235},"obj":"http://purl.obolibrary.org/obo/CLO_0008770"}],"text":"inct picture of B cell populations in COVID-19 compared to controls, whereas RD and HD were similar (Fig. 4J and fig. S5J). The COVID-19 patient B cell phenotype was dominated by loss of CXCR5 and IgD compared to B cells from HD and RD"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T231","span":{"begin":77,"end":79},"obj":"Chemical"},{"id":"T232","span":{"begin":84,"end":86},"obj":"Chemical"},{"id":"T233","span":{"begin":226,"end":228},"obj":"Chemical"},{"id":"T234","span":{"begin":233,"end":235},"obj":"Chemical"}],"attributes":[{"id":"A231","pred":"chebi_id","subj":"T231","obj":"http://purl.obolibrary.org/obo/CHEBI_73812"},{"id":"A232","pred":"chebi_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A233","pred":"chebi_id","subj":"T233","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A234","pred":"chebi_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/CHEBI_73812"}],"text":"inct picture of B cell populations in COVID-19 compared to controls, whereas RD and HD were similar (Fig. 4J and fig. S5J). The COVID-19 patient B cell phenotype was dominated by loss of CXCR5 and IgD compared to B cells from HD and RD"}